Schneidewind L, Kranz J, Zengerling F, Neumann T, et al. Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis. Clin Genitourin Cancer 2026;24:102611.
PMID: 42502035